论文信息 - Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation. - 字舞流文

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.

P. Schwartz | H. Tse | E. Valente | M. Mura | Federica Pisano | L. Crotti | M. Gnecchi | M. Ginevrino | M. Boni | Y. Lee | F. Calabrò

[1] P. Schwartz,et al. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model , 2018, European heart journal.

[2] P. Schwartz,et al. The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2. , 2017, International journal of cardiology.

[3] M. Mura,et al. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias. , 2017, International journal of cardiology.

[4] Stefano Severi,et al. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes , 2017, Cardiovascular research.

[5] Lia Crotti,et al. Long-QT syndrome: from genetics to management. , 2012, Circulation. Arrhythmia and electrophysiology.